Inequalities in care delivery and outcomes for myocardial infarction, heart failure, atrial fibrillation, and aortic stenosis in the United Kingdom
R Nadarajah, M Farooq, K Raveendra… - The Lancet Regional …, 2023 - thelancet.com
Cardiovascular diseases are a leading cause of death and disability globally, with
inequalities in burden and care delivery evident in Europe. To address this challenge, The …
inequalities in burden and care delivery evident in Europe. To address this challenge, The …
Closing the health equity gap: A role for implementation science?
B Odeny - PLoS Medicine, 2021 - journals.plos.org
Closing the health equity gap: A role for implementation science? | PLOS Medicine Skip to
main content Advertisement PLOS Medicine Browse Current Issue Journal Archive Special …
main content Advertisement PLOS Medicine Browse Current Issue Journal Archive Special …
South Asian ethnicity: What can we do to make this risk enhancer a risk equivalent?
South Asians account for around 25% of the global population and are the fastest-growing
ethnicity in the US. This population has an increasing burden of atherosclerotic …
ethnicity in the US. This population has an increasing burden of atherosclerotic …
Ethnic and socioeconomic disparities in initiation of second‐line antidiabetic treatment for people with type 2 diabetes in England: A cross‐sectional study
Aims To assess any disparities in the initiation of second‐line antidiabetic treatments
prescribed among people with type 2 diabetes mellitus (T2DM) in England according to …
prescribed among people with type 2 diabetes mellitus (T2DM) in England according to …
Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people
Background Some studies have shown that the incidence of type 2 diabetes increases after
a diagnosis of COVID-19, although the evidence is not conclusive. However, the effects of …
a diagnosis of COVID-19, although the evidence is not conclusive. However, the effects of …
Prevalence and factors associated with lipid-lowering medications use for primary and secondary prevention of cardiovascular diseases among Malaysians: The …
Background Lipid-lowering medications (LLM) are commonly used for secondary
prevention, as well as for primary prevention among patients with high global cardiovascular …
prevention, as well as for primary prevention among patients with high global cardiovascular …
Guideline-level monitoring, biomarker levels and pharmacological treatment in migrants and native Danes with type 2 diabetes: Population-wide analyses
AA Isaksen, A Sandbæk, MV Skriver… - PLOS Global Public …, 2023 - journals.plos.org
The prevalence of type 2 diabetes (T2D) is higher in migrants compared to native
populations in many countries, but the evidence on disparities in T2D care in migrants is …
populations in many countries, but the evidence on disparities in T2D care in migrants is …
The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: a population-scale analysis of …
Objectives To estimate the impact of the COVID-19 pandemic on cardiovascular disease
(CVD) and CVD management using routinely collected medication data as a proxy. Design …
(CVD) and CVD management using routinely collected medication data as a proxy. Design …
Mapping the Pharmacogenetic Landscape in a Ugandan Population: Implications for Personalized Medicine in an Underrepresented Population
Africans are extremely underrepresented in global genomic research. African populations
face high burdens of communicable and non‐communicable diseases and experience …
face high burdens of communicable and non‐communicable diseases and experience …
Performance of the pooled cohort equation in South Asians: insights from a large integrated healthcare delivery system
NM Mantri, M Merchant, JS Rana, AS Go… - BMC cardiovascular …, 2022 - Springer
South Asian ethnicity is associated with increased atherosclerotic cardiovascular disease
(ASCVD) risk and has been identified as a “risk enhancer” in the 2018 American College of …
(ASCVD) risk and has been identified as a “risk enhancer” in the 2018 American College of …